Conceptually-theoretical justification and updating of the preventive approach in the implementation of a pharmacist’s information consultancy services in the public health system

Cover Page

Cite item

Full Text

Abstract

Public health protection is the most important law of the development of a civilized society. As participants in the health care system, pharmaceutical specialists must take upon themselves certain preventive tasks aimed at strengthening and maintaining the health of the population.

The aim of the work was to substantiate and develop a methodology for implementing the professional role of pharmaceutical specialists in public health protection.

Materials and methods. The search for information was carried out using the methods of address, thematic and factual search in the Scopus, The Cochrane Library, Pubmed, eLibrary databases. The analyzed body of information included systematic reviews, retrospective and randomized studies, and other applied developments on the topic of publication. The depth of the bibliographic search for scientific publications is about 20 years (2000-2019). The following keywords were used for the search: “a pharmacist in health protection”, “prevention of adverse drug reactions”, “functions of a pharmacist”, “pharmaceutical care”, “sanitary competence”, “a pharmacist’s role in the prevention of diseases”, “pharmacy services”, “patient compliance”, “collaboration in health care”, etc.

Results. On the basis of the analysis, the demand for pharmacists in the health protection activities has been substantiated, the scientific and applied methodology of using pharmaceutical knowledge in the protection of public health has been updated and the necessary professional competencies (PC) of a pharmacist have been proposed for their implementation. The relevance of the preventive approach in the implementation of information and consultancy activities of a pharmacist has been substantiated, the essence of which is to prevent undesirable events associated with the use of medicinal preparations (MPs) and preventive health care in the society. The proposed methodology is based on the concept of “a pharmaceutical vigilance”, the practical implementation of which is proposed in the publication. The need for pharmacists to perform certain professional functions aimed at preserving and strengthening the health of the population has been updated, the functions have been proposed and the list of possible pharmaceutical services for the practical implementation of the proposed functions in the health care system has been provided.

Conclusion. The following pharmaceutical services have been identified as relevant: pharmaceutical enlightenment of the population, patient-oriented pharmaceutical counseling and patronage of patients, pharmaceutical informing of medical specialists about drugs and social prevention of the problems affecting the public health. The definitions of pharmaceutical services have been specified, the methodology for providing the services has been substantiated, the efficiency of their provision has been updated and the professional competencies of pharmacists for their implementation in practical healthcare have been formed.

About the authors

Irina A. Kirshchina

Perm State Pharmaceutical Academy

Author for correspondence.
Email: irina.kirshina@mail.ru
ORCID iD: 0000-0002-7952-9585

Candidate of Sciences (Pharmacy), Associate Professor of the Department of Management and Economics of Pharmacy

Russian Federation, 2, Polevaya St., Perm, 614990

Anna V. Soloninina

Perm State Pharmaceutical Academy

Email: soloninina@mail.ru
ORCID iD: 0000-0002-2745-7698

Doctor of Sciences (Pharmacy), the Head of the Department of Management and Economics

Russian Federation, 2, Polevaya St., Perm, 614990

Valentina N. Mikhailova

Perm State Pharmaceutical Academy

Email: mikhailov7ya@mail.ru
ORCID iD: 0000-0002-1705-705X

Candidate of Sciences (Pharmacy), Associate Professor of the Department of Management and Economics of Pharmacy

Russian Federation, 2, Polevaya St., Perm, 614990

References

  1. Vovk EI. [Bazovye principy farmakoterapii.] Russian pharmacies; 2003. 7–8: 47–51. Russian.
  2. Dremova NB., Ovod AI., Korzhavyh EA. Osnovy farmacevticheskoj pomoshchi v zdravoohranenii. Kursk State Medical University; 2009:412p. Russian.
  3. Fedina EA. Osnovy sistemy kachestva farmacevticheskih informacionno- konsul’tacionnyh uslug. Novaya apteka. Effektivnoe upravlenie. 2008;8:74–79. Russian.
  4. Kononova SV, Petrova SV, Dadus NN, CHesnokova NN, ZHukova EV. [Pharmaceutical consuting: efficacy and safety]. Remedium. 2019;(11):40–46. doi: 10.21518/1561-5936-2019-11-40-46.
  5. Maskaeva AR, Glembockaya GT. Integraciya deyatel’nosti provizora i vracha v obespechenie effektivnosti i bezopasnosti lekarstvennoj terapii. Pharmateka. 2001;4:24–31. Russian.
  6. Glembockaya GT. Mnogogrannost’, specifichnost’, otvetstvennost’ raboty provizora – specialista novogo tysyacheletiya. Vestnik voronezhskogo gosudarstvennogo universiteta. Seriya: Himiya. Biologiya. Pharmaciya. 2004;2:175–178. Russian.
  7. Zupanec IA, CHernyh VP, Popov SB. Farmacevticheskaya opeka: atlas. Kiev: Farmacevt Praktik. 2007:146p. Ukrainian.
  8. Zupanec IA, CHernyh VP, Popov SB, Bezdetko NV. Farmacevticheskaya opeka – vazhnejshij aspekt klinicheskoj farmacii. Provizor (Har’kov). 2000;11:6–9. Ukrainian
  9. Seubert LJ, Whitelaw K, Hattingh L, Watson MC, Clifford RM. Development of a Theory-Based Intervention to Enhance Information Exchange during Over-The-Counter Consultations in Community Pharmacy. Pharmacy (Basel). 2018;6(4):117. doi: 10.3390/pharmacy6040117.
  10. Gallelli L, Palleria C, De Vuono A, et al. Safety and efficacy of generic drugs with respect to brand formulation. J Pharmacol Pharmacother. 2013;4(1):S110–S114. doi: 10.4103/0976-500X.120972.
  11. Ertuna E, Arun MZ, Ay S, Koçak FÖK, Gökdemir B, İspirli G. Evaluation of pharmacist interventions and commonly used medications in the geriatric ward of a teaching hospital in Turkey: a retrospective study. Clin Interv Aging. 2019;14:587–600. doi: 10.2147/CIA.S201039.
  12. Hashimoto R, Fujii K,Yoshida K, Shimoji S, Masaki H, Kadoyama K, Nakamura T, Onda M. Outcomes of Pharmacists’ Involvement with Residents of Special Nursing Homes for the Elderly. Yakugaku Zasshi. 2018;138:1217–1225. doi: 10.1248/yakushi.18-00065.
  13. Parrish II RH, Casher D, van den Anker J, Benavides S. Creating a Pharmacotherapy Collaborative Practice Network to Manage Medications for Children and Youth: A Population Health Perspective. Children (Basel). 2019;6(4):58. doi: 10.3390/children6040058.
  14. Rieder M. Adverse Drug Reactions in Children: Pediatric Pharmacy and Drug Safety. Pediatr Pharmacol Ther. 2019;24(1):4–9. doi: 10.5863/1551-6776-24.1.4.
  15. Aston J, Wilson KA, Terry DRP. The treatment-related experiences of parents, children and young people with regular prescribed medication. Int J Clin Pharm. 2019;41(1):113–121. doi: 10.1007/s11096-018-0756-z.
  16. Loustalot MC, Berdot S, Sabatier P, et al. The impact of interventions by pharmacists collected in a computerised physician order entry context: a prospective observational study with a 10-year reassessment. Swiss Medical Weekly. 2019;149:w20015. doi: 10.4414/smw.2019.20015.
  17. Kennedy MJ. Personalized medicines – are pharmacists ready for the challenge? Integr Pharm Res Pract. 2018;7:113–123. doi: 10.2147/IPRP.S133083
  18. Percev IM, Zupanuc IA. Biofarmaciya i effektivnost’ lekarstv. Provizor. 2001;4: 25-28. Russian.
  19. SHabunova AA, Kalachikova ON, SHabunova AA, Kalashnikov KN. Obshchestvennoe zdorov’e i zdravoohranenie territorij. Vologda: «ISERT RAN». 2010:211. Russian
  20. Lisicyn YUP. Obshchestvennoe zdorov’e i zdravoohranenie. Moscow: GEOTAR-Media.2009:512p. Russian.
  21. Mononen N, Airaksinen MSA, Hämeen-Anttila K, Helakorpi S, Pohjanoksa-Mäntylä M. Trends in the receipt of medicines information among Finnish adults in 1999-2014: a nationwide repeated cross-sectional survey. BMJ Open. 2019;9(6):e026377. doi: 10.1136/bmjopen-2018-026377.
  22. Garov S. [Sanitary literacy – determining health factor]. Nacional’naya Associaciya Uchenyh. 2018;37:12–15. Russian.
  23. Popov T, Garov S. [About nature and priorities of sanitary education]. Vestnik Vostochno-Sibirskoj Otkrytoj Akademii. 2018; 27:14p. Russian.
  24. Nutbeam D. Health literacy as a public health goal: a challenge for contemporary health education and communication strategies into the 21st century. Health Promotion International. 2000;15(3):259–267. doi.org/10.1093/heapro/15.3.259.
  25. Amlaev KR, Dakhkilgova KhT. Health literacy matters: concept, classification, methods of assessment. Vrach. 2018; 29(6):83–86. Russian.
  26. Gabdrafikova YuS, Kirshchina IA, Soloninina AV. [Farmaceutical help for geriatric patients: vital problems and possible solutions]. Pharmacy. 2018; 5: 35–41. DOI.org/10.29296/25419218-2018-05-07. Russian.
  27. Abdulhabirova FM, et al. Obshchaya vrachebnaya praktika. Moscow: “GEOTAR-Media”. 2020:1024p. Russian.
  28. Sychev DA, Sosnovskij EE, Orekhov RE, Bordovskij SP. Contemporary methods of dealing.With polypharmacy in elderly and senile patients. Siberian medical review. 2016;2:13–21. Russian.
  29. Sychev D.A. Polipragmaziya i bezopasnost’ pacientov. Medical alphabet. 2015; 2(9):52. Russian.
  30. Adherence to Long-Term Therapies: Evidence for Action. [Internet]. WHO; 2003:16p. Available from: https://www.who.int/chp/knowledge/publications/adherence_report/en/
  31. Vol’skaya EA. Patient compliance. Overview of research trends. Remedium. 2013;11:6–15. doi: 10.21518/1561-5936-2013-11-6-15.
  32. Kluchnikov S.O. Polypharmacy: response. Children infections. 2014;13(4):36–41. doi: 10.22627/2072-8107-2014-13-4-36-4. Russian.
  33. The Pursuit of Responsible Use of Medicines:Sharing and Learning from Country Experiences. [Internet]. WHO; 2012:78p. Available from: https://www.who.int/medicines/publications/responsible_use/en/. Russian.
  34. Developing pharmacy practice. A focus on patient care. Geneva. [Internet]. WHO; 2003:97p. Available from: https://www.who.int/medicines/publications/WHO_PSM_PAR_2006.5.pdf. Russian.
  35. The Role of Education in the Rational Use of Medicines. [Internet]. WHO. 2006:99p. Available from::https://digicollections.net/medicinedocs/documents/s16792e/s16792e.pdf. Russian.
  36. The legal and regulatory framework for community pharmacies in the WHO European Region. [Internet]. World Health Organization. Regional Office for Europe 2020:112p. Available from: https://apps.who.int/iris/bitstream/handle/10665/331232/9789289054591-rus.pdf. Russian.
  37. Létinier L, Cossin S, Mansiaux Y, Arnaud M, Salvo F, Bezin J, Thiessard F, Pariente A. Risk of Drug-Drug Interactions in Out-Hospital Drug Dispensings in France: Results From the DRUG-Drug Interaction Prevalence Study. Front Pharmacol. 2019;10:265. doi: 10.3389/fphar.2019.00265.
  38. Molokhia M, Majeed A. Current and future perspectives on the management of polypharmacy. BMC Fam Pract. 2017;18(1):70. doi: 10.1186/s12875-017-0642-0.
  39. Garzón González G, Montero Morales L, de Miguel García S, Jiménez Domínguez C, Domínguez Pérez N, Mediavilla Herrera I. Análisis descriptivo de los errores de medicación notificados en atención primaria: aprendiendo de nuestros errores [Descriptive analysis of medication errors notified by Primary Health Care: Learning from errors]. Aten Primaria. 2020;52(4):233–239. Spanish. doi: 10.1016/j.aprim.2019.01.006.
  40. HEALTH21: the health for all policy framework for the WHO European Region. [Internet]. Copenhagen, WHO. 1999:314p. Available from: https://www.euro.who.int/ru/publications/abstracts/health21-the-health-for-all-policy-framework-for-the-who-european-region. Russian.
  41. European Action Plan for Strengthening Public Health Capacities and Services. [Internet]. WHO. 2012:52p. Available from: https://www.euro.who.int/ru/health-topics/Health-systems/public-health-services/publications/2012/european-action-plan-for-strengthening-public-health-capacities-and-services. Russian.
  42. Strengthening people-centred health systems in the WHO European Region: framework for action on integrated health services delivery. WHO. 2016:56p. Available from: https://www.euro.who.int/ru/health-topics/Health-systems/pages/publications/2016/eurrc6615-strengthening-people-centred-health-systems-in-the-who-european-region-framework-for-action-on-integrated-health-services-delivery. Russian.
  43. Gaining health. The European Strategy for the Prevention and Control of Noncommunicable Diseases. [Internet]. Denmark, WHO. 2006:66p. Available from: https://www.euro.who.int/ru/publications/abstracts/gaining-health.-the-european-strategy-for-the-prevention-and-control-of-noncommunicable-diseases. Russian.
  44. Smolina VA, Novokreshchenova IG. INTERDISCIPLINARY APPROACH TO THE STUDY OF PHARMACEUTICAL CARE IN THE PROBLEM FIELD OF SOCIOLOGY OF MEDICINE (REVIEW). Saratov Journal of Medical ScientificResearch. 2017;13(2):295–299. Russian
  45. Kasavin IT. Filosofiya poznaniya i ideya mezhdisciplinarnosti. Epistemology & Philosophy of Science. 2004: 2(2):5–13. Russian.
  46. Cavanaugh JJ, Lindsey KN, Shilliday BB, Ratner SP. Pharmacist-coordinated multidisciplinary hospital follow-up visits improve patient outcomes. J Manag Care Spec Pharm. 2015;21(3):256–60. doi: 10.18553/jmcp.2015.21.3.256.
  47. Rojas E, Gerber BS, Tilton J, Rapacki L, Sharp LK. Pharmacists’ perspectives on collaborating with community health workers in diabetes care. J Am Pharm Assoc (2003). 2015;55(4):429–33. doi: 10.1331/JAPhA.2015.14123.
  48. Colla CH, Lewis VA, Beaulieu-Jones BR, Morden NE. Role of pharmacy services in accountable care organizations. J Manag Care Spec Pharm. 2015;21(4):338–44. doi: 10.18553/jmcp.2015.21.4.338.
  49. Kennedy MJ. Personalized medicines – are pharmacists ready for the challenge? Integr Pharm Res Pract. 2018;7:113–123. doi: 10.2147/IPRP.S133083.
  50. Johansen JS, Havnes K, Halvorsen KH, et al. Interdisciplinary collaboration across secondary and primary care to improve medication safety in the elderly (IMMENSE study): study protocol for a randomised controlled trial. BMJ Open. 2018;8(1):e020106. doi: 10.1136/bmjopen-2017-020106.
  51. Ensing HT, Vervloet M, van Dooren AA, Bouvy ML, Koster ES. Patient-pharmacist communication during a post-discharge pharmacist home visit. Int J Clin Pharm. 2018;40(3):712–720. doi: 10.1007/s11096-018-0639-3.
  52. Eickhoff C, Müller U, Strunz AK, Seidling HM, Lampert A, Felberg M, Breiholz S, Klintworth D, Schulz M. Das Projekt PRIMA – Elektronische Erstellung und Aktualisierung von Medikationsplänen als gemeinsame Aufgabe von Ärzten und Apothekern [The PRIMA Project – Electronically-Supported Physician-Pharmacist Cooperation to Generate and Update Medication Plans in Germany]. Dtsch Med Wochenschr. 2019;144(18):e114–e120. German. doi: 10.1055/a-0859-5862.
  53. Amara S, Adamson RT, Lew I, Slonim A. Accountable care organizations: impact on pharmacy. Hosp Pharm. 2014 Mar;49(3):253–9. doi: 10.1310/hpj4903-253.
  54. Novik AA, Ionova TI. Rukovodstvo po issledovaniyu kachestva zhizni v medicine. 2nd ed. Moscow: ZAO «Olma Media Grupp. 2007:320p. Russian.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download
2. Figure 1 – Functional-applied model of the formation of information consultancy competencies of pharmacy specialists from the standpoint of a preventive approach

Download (283KB)
Indexing metadata

Copyright (c) 2020 Kirshchina I.A., Soloninina A.V., Michailova V.N.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
 

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies